Skip to content

Clinical trials

Completed Cardiovascular Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Completed Country / region: Taiwan Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20071
20082
20093
20103
20113
20123
20131
20143
20151
20161
20171
20185
20194
20214
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Chang Gung Memorial Hospital3
AstraZeneca2
Cardurion Pharmaceuticals, Inc.2
China Medical University Hospital2
National Defense Medical Center, Taiwan2
National Taiwan Sport University2
National Taiwan University Hospital2
National Yang Ming Chiao Tung University2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases44
Heart Diseases6
Stroke6
Metabolic Syndrome5
Coronary Disease4
Diabetes Mellitus, Type 24
Hypertension4
Renal Insufficiency, Chronic4
Acute Coronary Syndrome3
Atherosclerosis3

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.